
Digital pathology refers to the application of computers and networks to the field of pathology, which is a technology that organically combines modern digital systems with traditional optical amplification devices.
The global market for Digtal Patology was estimated to be worth US$ 3241 million in 2023 and is forecast to a readjusted size of US$ 5842.3 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030
North American market for Digtal Patology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Digtal Patology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Digtal Patology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Digtal Patology include Thermo Fisher, Hoffmann-La Roche, Hamamatsu Photonics, 3DHISTECH, Koninklijke Philips N.V., Apollo, Sectra, Huron Technologies and Vital Signs Solutions, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digtal Patology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digtal Patology by region & country, by Type, and by Application.
The Digtal Patology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digtal Patology.
Market Segmentation
By Company
Thermo Fisher
Hoffmann-La Roche
Hamamatsu Photonics
3DHISTECH
Koninklijke Philips N.V.
Apollo
Sectra
Huron Technologies
Vital Signs Solutions
Visiopharm
Segment by Type:
Hardware
Software
Segment by Application
Hospitals
Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digtal Patology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digtal Patology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digtal Patology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Digtal Patology Product Introduction
1.2 Global Digtal Patology Market Size Forecast
1.3 Digtal Patology Market Trends & Drivers
1.3.1 Digtal Patology Industry Trends
1.3.2 Digtal Patology Market Drivers & Opportunity
1.3.3 Digtal Patology Market Challenges
1.3.4 Digtal Patology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digtal Patology Players Revenue Ranking (2023)
2.2 Global Digtal Patology Revenue by Company (2019-2024)
2.3 Key Companies Digtal Patology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Digtal Patology Product Offered
2.5 Key Companies Time to Begin Mass Production of Digtal Patology
2.6 Digtal Patology Market Competitive Analysis
2.6.1 Digtal Patology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Digtal Patology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digtal Patology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hardware
3.1.2 Software
3.2 Global Digtal Patology Sales Value by Type
3.2.1 Global Digtal Patology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digtal Patology Sales Value, by Type (2019-2030)
3.2.3 Global Digtal Patology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Laboratories
4.1.3 Others
4.2 Global Digtal Patology Sales Value by Application
4.2.1 Global Digtal Patology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digtal Patology Sales Value, by Application (2019-2030)
4.2.3 Global Digtal Patology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Digtal Patology Sales Value by Region
5.1.1 Global Digtal Patology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digtal Patology Sales Value by Region (2019-2024)
5.1.3 Global Digtal Patology Sales Value by Region (2025-2030)
5.1.4 Global Digtal Patology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Digtal Patology Sales Value, 2019-2030
5.2.2 North America Digtal Patology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Digtal Patology Sales Value, 2019-2030
5.3.2 Europe Digtal Patology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Digtal Patology Sales Value, 2019-2030
5.4.2 Asia Pacific Digtal Patology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Digtal Patology Sales Value, 2019-2030
5.5.2 South America Digtal Patology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Digtal Patology Sales Value, 2019-2030
5.6.2 Middle East & Africa Digtal Patology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digtal Patology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digtal Patology Sales Value
6.3 United States
6.3.1 United States Digtal Patology Sales Value, 2019-2030
6.3.2 United States Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digtal Patology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digtal Patology Sales Value, 2019-2030
6.4.2 Europe Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digtal Patology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digtal Patology Sales Value, 2019-2030
6.5.2 China Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digtal Patology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digtal Patology Sales Value, 2019-2030
6.6.2 Japan Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digtal Patology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digtal Patology Sales Value, 2019-2030
6.7.2 South Korea Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digtal Patology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digtal Patology Sales Value, 2019-2030
6.8.2 Southeast Asia Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digtal Patology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digtal Patology Sales Value, 2019-2030
6.9.2 India Digtal Patology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digtal Patology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Profile
7.1.2 Thermo Fisher Main Business
7.1.3 Thermo Fisher Digtal Patology Products, Services and Solutions
7.1.4 Thermo Fisher Digtal Patology Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Recent Developments
7.2 Hoffmann-La Roche
7.2.1 Hoffmann-La Roche Profile
7.2.2 Hoffmann-La Roche Main Business
7.2.3 Hoffmann-La Roche Digtal Patology Products, Services and Solutions
7.2.4 Hoffmann-La Roche Digtal Patology Revenue (US$ Million) & (2019-2024)
7.2.5 Hoffmann-La Roche Recent Developments
7.3 Hamamatsu Photonics
7.3.1 Hamamatsu Photonics Profile
7.3.2 Hamamatsu Photonics Main Business
7.3.3 Hamamatsu Photonics Digtal Patology Products, Services and Solutions
7.3.4 Hamamatsu Photonics Digtal Patology Revenue (US$ Million) & (2019-2024)
7.3.5 3DHISTECH Recent Developments
7.4 3DHISTECH
7.4.1 3DHISTECH Profile
7.4.2 3DHISTECH Main Business
7.4.3 3DHISTECH Digtal Patology Products, Services and Solutions
7.4.4 3DHISTECH Digtal Patology Revenue (US$ Million) & (2019-2024)
7.4.5 3DHISTECH Recent Developments
7.5 Koninklijke Philips N.V.
7.5.1 Koninklijke Philips N.V. Profile
7.5.2 Koninklijke Philips N.V. Main Business
7.5.3 Koninklijke Philips N.V. Digtal Patology Products, Services and Solutions
7.5.4 Koninklijke Philips N.V. Digtal Patology Revenue (US$ Million) & (2019-2024)
7.5.5 Koninklijke Philips N.V. Recent Developments
7.6 Apollo
7.6.1 Apollo Profile
7.6.2 Apollo Main Business
7.6.3 Apollo Digtal Patology Products, Services and Solutions
7.6.4 Apollo Digtal Patology Revenue (US$ Million) & (2019-2024)
7.6.5 Apollo Recent Developments
7.7 Sectra
7.7.1 Sectra Profile
7.7.2 Sectra Main Business
7.7.3 Sectra Digtal Patology Products, Services and Solutions
7.7.4 Sectra Digtal Patology Revenue (US$ Million) & (2019-2024)
7.7.5 Sectra Recent Developments
7.8 Huron Technologies
7.8.1 Huron Technologies Profile
7.8.2 Huron Technologies Main Business
7.8.3 Huron Technologies Digtal Patology Products, Services and Solutions
7.8.4 Huron Technologies Digtal Patology Revenue (US$ Million) & (2019-2024)
7.8.5 Huron Technologies Recent Developments
7.9 Vital Signs Solutions
7.9.1 Vital Signs Solutions Profile
7.9.2 Vital Signs Solutions Main Business
7.9.3 Vital Signs Solutions Digtal Patology Products, Services and Solutions
7.9.4 Vital Signs Solutions Digtal Patology Revenue (US$ Million) & (2019-2024)
7.9.5 Vital Signs Solutions Recent Developments
7.10 Visiopharm
7.10.1 Visiopharm Profile
7.10.2 Visiopharm Main Business
7.10.3 Visiopharm Digtal Patology Products, Services and Solutions
7.10.4 Visiopharm Digtal Patology Revenue (US$ Million) & (2019-2024)
7.10.5 Visiopharm Recent Developments
8 Industry Chain Analysis
8.1 Digtal Patology Industrial Chain
8.2 Digtal Patology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digtal Patology Sales Model
8.5.2 Sales Channel
8.5.3 Digtal Patology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher
Hoffmann-La Roche
Hamamatsu Photonics
3DHISTECH
Koninklijke Philips N.V.
Apollo
Sectra
Huron Technologies
Vital Signs Solutions
Visiopharm
Ìý
Ìý
*If Applicable.
